First Time Loading...
H

Hbm Holdings Ltd
HKEX:2142

Watchlist Manager
Hbm Holdings Ltd
HKEX:2142
Watchlist
Price: 1.15 HKD 6.48% Market Closed
Updated: Apr 23, 2024

Intrinsic Value

Hbm Holdings Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

HBM Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutics in the fields of immuno-oncology and immunology diseases. [ Read More ]

The intrinsic value of one Hbm Holdings Ltd stock under the Base Case scenario is 6.93 HKD. Compared to the current market price of 1.15 HKD, Hbm Holdings Ltd is Undervalued by 83%.

Key Points:
Intrinsic Value
Base Case
6.93 HKD
Undervaluation 83%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Hbm Holdings Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Hbm Holdings Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Hbm Holdings Ltd

Provide an overview of the primary business activities
of Hbm Holdings Ltd.

What unique competitive advantages
does Hbm Holdings Ltd hold over its rivals?

What risks and challenges
does Hbm Holdings Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hbm Holdings Ltd.

Provide P/S
for Hbm Holdings Ltd.

Provide P/E
for Hbm Holdings Ltd.

Provide P/OCF
for Hbm Holdings Ltd.

Provide P/FCFE
for Hbm Holdings Ltd.

Provide P/B
for Hbm Holdings Ltd.

Provide EV/S
for Hbm Holdings Ltd.

Provide EV/GP
for Hbm Holdings Ltd.

Provide EV/EBITDA
for Hbm Holdings Ltd.

Provide EV/EBIT
for Hbm Holdings Ltd.

Provide EV/OCF
for Hbm Holdings Ltd.

Provide EV/FCFF
for Hbm Holdings Ltd.

Provide EV/IC
for Hbm Holdings Ltd.

Show me price targets
for Hbm Holdings Ltd made by professional analysts.

What are the Revenue projections
for Hbm Holdings Ltd?

How accurate were the past Revenue estimates
for Hbm Holdings Ltd?

What are the Net Income projections
for Hbm Holdings Ltd?

How accurate were the past Net Income estimates
for Hbm Holdings Ltd?

What are the EPS projections
for Hbm Holdings Ltd?

How accurate were the past EPS estimates
for Hbm Holdings Ltd?

What are the EBIT projections
for Hbm Holdings Ltd?

How accurate were the past EBIT estimates
for Hbm Holdings Ltd?

Compare the revenue forecasts
for Hbm Holdings Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hbm Holdings Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hbm Holdings Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hbm Holdings Ltd compared to its peers.

Compare the P/E ratios
of Hbm Holdings Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hbm Holdings Ltd with its peers.

Analyze the financial leverage
of Hbm Holdings Ltd compared to its main competitors.

Show all profitability ratios
for Hbm Holdings Ltd.

Provide ROE
for Hbm Holdings Ltd.

Provide ROA
for Hbm Holdings Ltd.

Provide ROIC
for Hbm Holdings Ltd.

Provide ROCE
for Hbm Holdings Ltd.

Provide Gross Margin
for Hbm Holdings Ltd.

Provide Operating Margin
for Hbm Holdings Ltd.

Provide Net Margin
for Hbm Holdings Ltd.

Provide FCF Margin
for Hbm Holdings Ltd.

Show all solvency ratios
for Hbm Holdings Ltd.

Provide D/E Ratio
for Hbm Holdings Ltd.

Provide D/A Ratio
for Hbm Holdings Ltd.

Provide Interest Coverage Ratio
for Hbm Holdings Ltd.

Provide Altman Z-Score Ratio
for Hbm Holdings Ltd.

Provide Quick Ratio
for Hbm Holdings Ltd.

Provide Current Ratio
for Hbm Holdings Ltd.

Provide Cash Ratio
for Hbm Holdings Ltd.

What is the historical Revenue growth
over the last 5 years for Hbm Holdings Ltd?

What is the historical Net Income growth
over the last 5 years for Hbm Holdings Ltd?

What is the current Free Cash Flow
of Hbm Holdings Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hbm Holdings Ltd.

Financials

Balance Sheet Decomposition
Hbm Holdings Ltd

Current Assets 210.2m
Cash & Short-Term Investments 140.3m
Receivables 52.3m
Other Current Assets 17.5m
Non-Current Assets 18.3m
Long-Term Investments 5.7m
PP&E 4.9m
Intangibles 7.7m
Current Liabilities 64.1m
Accounts Payable 15.4m
Other Current Liabilities 48.8m
Non-Current Liabilities 44.4m
Long-Term Debt 28.6m
Other Non-Current Liabilities 15.8m
Efficiency

Earnings Waterfall
Hbm Holdings Ltd

Revenue
89.5m USD
Cost of Revenue
-2m USD
Gross Profit
87.5m USD
Operating Expenses
-60.4m USD
Operating Income
27.1m USD
Other Expenses
-4.3m USD
Net Income
22.8m USD

Free Cash Flow Analysis
Hbm Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hbm Holdings Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional ROIC
Exceptional 1-Year Revenue Growth
44/100
Profitability
Score

Hbm Holdings Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hbm Holdings Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
76/100
Solvency
Score

Hbm Holdings Ltd's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hbm Holdings Ltd

Wall Street analysts forecast Hbm Holdings Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hbm Holdings Ltd is 1.72 HKD .

Lowest
Price Target
Not Available
Average
Price Target
1.72 HKD
50% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Hbm Holdings Ltd

1M 1M
-17%
6M 6M
-16%
1Y 1Y
-44%
3Y 3Y
-88%
5Y 5Y
-90%
10Y 10Y
-90%
Annual Price Range
1.15
52w Low
1.04
52w High
2.11
Price Metrics
Average Annual Return -31.27%
Standard Deviation of Annual Returns 25.58%
Max Drawdown -93%
Shares Statistics
Market Capitalization 883.7m HKD
Shares Outstanding 736 164 550
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Hbm Holdings Ltd

Country

Hong Kong

Industry

Biotechnology

Market Cap

883.7m HKD

Dividend Yield

0%

Description

HBM Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutics in the fields of immuno-oncology and immunology diseases. The Company’s products include batoclimab, mainly used for immune thrombocytopenia (ITP), graves’ ophthalmopathy (GO), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD); and tanfanercept, mainly used for dry eye disease (DED). In addition, the Company researches and develops immuno-oncology portfolio, including internally developed next-generation immune-oncology assets targeting immune-desert, immune-excluded and inflamed tumors.

Contact

Level 54, Hopewell Centre, 183 Queen's Road East, Wan Chai
https://www.harbourbiomed.com/

IPO

2020-12-10

Employees

318

Officers

Founder, Chairman & CEO
Dr. Jingsong Wang M.D., Ph.D.
CFO, Chief Business Officer and Global Head of Business & Corporate Development
Mr. Weihao Xu
Chief Scientific Officer & Executive Director
Dr. Yiping Rong Ph.D.
Head of Legal
Mr. Bruce Zhang
Member of Scientific Advisory Board & Chief CMC Advisor
Dr. Peter F. Moesta Ph.D.
Chief Development Officer
Dr. Xiaolu Tao
Show More
Chief Scientific Advisor
Dr. Steve Arkinstall DPhil
Company Secretary
Mr. Wing Yat Lui
Show Less

See Also

Discover More
What is the Intrinsic Value of one Hbm Holdings Ltd stock?

The intrinsic value of one Hbm Holdings Ltd stock under the Base Case scenario is 6.93 HKD.

Is Hbm Holdings Ltd stock undervalued or overvalued?

Compared to the current market price of 1.15 HKD, Hbm Holdings Ltd is Undervalued by 83%.